Award

Evaluation of Buvidal

LLYWODRAETH CYMRU / WELSH GOVERNMENT

This public procurement record has 2 releases in its history.

Award

08 Mar 2023 at 00:00

Tender

15 Dec 2022 at 00:00

Summary of the contracting process

The Welsh Government has awarded a contract for the Evaluation of Buvidal to USW Commercial Services Ltd. The evaluation focuses on the rapid implementation of Injectable Buprenorphine (Buvidal) as part of opioid substitution treatment (OST) services. The contract, valued at £399,990, was signed on 8th March 2023. The procurement process was completed under the open procedure for services. The evaluation includes stages to assess setup, theory of change, and overall effectiveness of Buvidal, offering business growth opportunities in the healthcare services sector.

This tender by the Welsh Government presents opportunities for businesses in the healthcare and pharmaceutical sectors to engage in the evaluation of cutting-edge medical interventions like Buvidal. With a strong emphasis on effectiveness assessment and economic evaluation, businesses with expertise in healthcare research, intervention evaluation, and service effectiveness measurement would be well-suited to bid for this contract. The inclusion of community benefits and consortia bidding further widens the scope for business growth and collaboration in this competitive procurement process.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Evaluation of Buvidal

Notice Description

The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections.

Lot Information

Lot 1

The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections. The evaluation will have both backward - and forward - looking components and will serve three aims: Stage one: To assess how the programme has been set up and how it is being operated (backward looking). Stage one will also be used to assess the feasibility of adopting a randomised controlled trial methodology for stage three and/or suggest other models if appropriate. Stage two: To elucidate the theory of change for Buvidal and develop the logic model underpinning the treatment, considering the differences between Buvidal and other OST and what the 'new' service should look like. Stage three: To provide an indication of its overall effectiveness and an economic evaluation (including any differences between outcomes for those on Buvidal and other OST medications).

Renewal: An extension of up to a further 24 months.

Publication & Lifecycle

Open Contracting ID
ocds-kuma6s-127356
Publication Source
Sell2Wales
Latest Notice
https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=127356
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

73 - Research and development services and related consultancy services

79 - Business services: law, marketing, consulting, recruitment, printing and security


CPV Codes

73000000 - Research and development services and related consultancy services

73100000 - Research and experimental development services

73110000 - Research services

73200000 - Research and development consultancy services

73210000 - Research consultancy services

79300000 - Market and economic research; polling and statistics

79310000 - Market research services

79315000 - Social research services

Notice Value(s)

Tender Value
£650,000 £500K-£1M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£399,990 £100K-£500K

Notice Dates

Publication Date
8 Mar 20232 years ago
Submission Deadline
6 Feb 2023Expired
Future Notice Date
Not specified
Award Date
8 Mar 20232 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
LLYWODRAETH CYMRU / WELSH GOVERNMENT
Contact Name
Not specified
Contact Email
cpsprocurementadvice@gov.wales
Contact Phone
+44 3000257095

Buyer Location

Locality
CAERDYDD / CARDIFF
Postcode
CF10 3NQ
Post Town
Cardiff
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
TLL Wales

Local Authority
Cardiff
Electoral Ward
Cathays
Westminster Constituency
Cardiff South and Penarth

Supplier Information

Number of Suppliers
1
Supplier Name

USW COMMERCIAL SERVICES

Further Information

Notice Documents

  • https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=DEC421678
    Evaluation of Buvidal - The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections.
  • https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=MAR430249
    Evaluation of Buvidal - The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-kuma6s-127356-2023-03-08T00:00:00Z",
    "date": "2023-03-08T00:00:00Z",
    "ocid": "ocds-kuma6s-127356",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-27",
            "name": "Llywodraeth Cymru / Welsh Government",
            "identifier": {
                "legalName": "Llywodraeth Cymru / Welsh Government"
            },
            "address": {
                "streetAddress": "Gwasanaethau Caffael Corfforaethol / Corporate Procurement Services, Parc Cathays / Cathays Park",
                "locality": "Caerdydd / Cardiff",
                "region": "UKL",
                "postalCode": "CF10 3NQ"
            },
            "contactPoint": {
                "email": "CPSProcurementAdvice@gov.wales",
                "telephone": "+44 3000257095",
                "url": "https://www.etenderwales.bravosolution.co.uk"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Ministry or any other national or federal authority, including their regional or local subdivisions",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "01",
                        "description": "General public services",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://gov.wales"
            }
        },
        {
            "id": "org-2",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        },
        {
            "id": "org-231",
            "name": "Llywodraeth Cymru / Welsh Government",
            "identifier": {
                "legalName": "Llywodraeth Cymru / Welsh Government"
            },
            "address": {
                "streetAddress": "Gwasanaethau Caffael Corfforaethol / Corporate Procurement Services, Parc Cathays / Cathays Park",
                "locality": "Caerdydd / Cardiff",
                "region": "UKL",
                "postalCode": "CF10 3NQ"
            },
            "contactPoint": {
                "email": "CPSProcurementAdvice@gov.wales",
                "telephone": "+44 3000257095"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Ministry or any other national or federal authority, including their regional or local subdivisions",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "01",
                        "description": "General public services",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://gov.wales"
            }
        },
        {
            "id": "org-232",
            "name": "USW Commercial Services Ltd",
            "identifier": {
                "legalName": "USW Commercial Services Ltd"
            },
            "address": {
                "streetAddress": "University of South Wales, Llantwit Road Treforest",
                "locality": "Pontypridd",
                "region": "UK",
                "postalCode": "CF371DL"
            },
            "contactPoint": {
                "telephone": "+44 1443482482",
                "faxNumber": "+44 1443485916"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "org-3",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "Llywodraeth Cymru / Welsh Government",
        "id": "org-231"
    },
    "tender": {
        "id": "ocds-kuma6s-127356-tender-129818-C195/2022/2023",
        "title": "Evaluation of Buvidal",
        "description": "The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "73100000",
                        "scheme": "CPV"
                    },
                    {
                        "id": "73110000",
                        "scheme": "CPV"
                    },
                    {
                        "id": "73200000",
                        "scheme": "CPV"
                    },
                    {
                        "id": "73210000",
                        "scheme": "CPV"
                    },
                    {
                        "id": "79300000",
                        "scheme": "CPV"
                    },
                    {
                        "id": "79310000",
                        "scheme": "CPV"
                    },
                    {
                        "id": "79315000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL"
                    },
                    {
                        "region": "UKL"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amount": 650000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "services",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://www.etenderwales.bravosolution.co.uk",
        "tenderPeriod": {
            "endDate": "2023-02-06T14:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2023-02-07T09:30:00Z"
        },
        "documents": [
            {
                "id": "DEC421678",
                "documentType": "contractNotice",
                "title": "Evaluation of Buvidal",
                "description": "The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections.",
                "url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=DEC421678",
                "format": "text/html"
            },
            {
                "id": "economic",
                "documentType": "economicSelectionCriteria"
            },
            {
                "id": "technical",
                "documentType": "technicalSelectionCriteria"
            },
            {
                "id": "MAR430249",
                "documentType": "awardNotice",
                "title": "Evaluation of Buvidal",
                "description": "The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections.",
                "url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=MAR430249",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections. The evaluation will have both backward - and forward - looking components and will serve three aims: Stage one: To assess how the programme has been set up and how it is being operated (backward looking). Stage one will also be used to assess the feasibility of adopting a randomised controlled trial methodology for stage three and/or suggest other models if appropriate. Stage two: To elucidate the theory of change for Buvidal and develop the logic model underpinning the treatment, considering the differences between Buvidal and other OST and what the 'new' service should look like. Stage three: To provide an indication of its overall effectiveness and an economic evaluation (including any differences between outcomes for those on Buvidal and other OST medications).",
                "status": "complete",
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 720
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "An extension of up to a further 24 months."
                },
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "The proposed methodology, detailing how the aims, objectives and requirements (section 2 within the specification) of the project will be addressed.",
                            "description": "30"
                        },
                        {
                            "type": "price",
                            "description": "20"
                        }
                    ]
                }
            }
        ],
        "bidOpening": {
            "date": "2023-02-07T09:30:00Z"
        },
        "contractTerms": {
            "performanceTerms": "As stated in the tender documentation."
        },
        "coveredBy": [
            "GPA"
        ],
        "otherRequirements": {
            "requiresStaffNamesAndQualifications": true
        },
        "submissionTerms": {
            "languages": [
                "en",
                "cy"
            ],
            "bidValidityPeriod": {
                "durationInDays": 180
            }
        },
        "classification": {
            "id": "73000000",
            "scheme": "CPV"
        },
        "hasRecurrence": false,
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "language": "EN",
    "description": "E-TENDER INFORMATION: https://etenderwales.bravosolution.co.uk - The first person from your Organisation to use the Platform will be required to register on behalf of the Organisation. - Registration involves accepting a User Agreement, and providing basic information about your Organisation and about the User performing the Registration. - The User who performs the Registration becomes the Super User for the Organisation. - On registering on the Platform the Super User will select a Username and will receive a password. - The Password will be sent by e-mail to the email address that was specified in the User Details section of the Registration page. - In order to log-in to the Platform please enter your Username and Password. - Note: If you forget your Password then visit the homepage and click \"Forgot your password?\" - Registration should only be performed once for each Organisation. - If you think that someone in your Organisation may have already registered on this Platform then you must not register again. - Please contact the person who Registered (i.e. the Super User) in order to arrange access to the Platform. - Contact the Helpdesk immediately if you are unable to contact the Super User (for example if they have left your Organisation). - Note: If your Organisation is already registered on the Platform then you must not make any additional registration. Please contact the Helpdesk to gain access to the Platform. - Tenders must be uploaded to the BravoSolution portal by 2pm HOW TO FIND THE ITT: - Once logged in you must click on 'ITT's Open to all Suppliers' - The etender references for this contract are: Project_52033 and ITT _99855 - Click on the title to access summary details of the contract. If you are still interested in submitting a tender, click the 'Express an Interest button'. This will move the ITT from the 'Open to all Suppliers' area to the 'My ITT's' on the home page. - You will then see the full details of the ITT in the qualification and technical envelopes along with any relevant documents in the 'Attachments' area. - Should you have any questions on the ITT, please use the 'Messages' area to contact the buyer directly - Please do not contact the named person at the top of this notice. NOTE: The authority is using eTenderwales to carry out this procurement process.To obtain further information record your interest on Sell2Wales at http://www.sell2wales.gov.wales/search/search_switch.aspx?ID= 127356 (WA Ref:127356) Under the terms of this contract the successful supplier(s) will be required to deliver Community Benefits in support of the authority's economic and social objectives. Accordingly, contract performance conditions may relate in particular to social and environmental considerations. The Community Benefits included in this contract are: as described in the tender documents The buyer considers that this contract is suitable for consortia bidding. (WA Ref:129818)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-127356"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "awards": [
        {
            "id": "ocds-kuma6s-127356-award-129818-175",
            "suppliers": [
                {
                    "id": "org-232",
                    "name": "USW Commercial Services Ltd"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "ocds-kuma6s-127356-award-129818-175",
            "awardID": "ocds-kuma6s-127356-award-129818-175",
            "status": "active",
            "value": {
                "amount": 399990,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-08T00:00:00Z"
        }
    ],
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2022/S 000-035551"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "ocds-kuma6s-127356-bidsstatistic-129818-657",
                "measure": "bids",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "ocds-kuma6s-127356-bidsstatistic-129818-658",
                "measure": "smeBids",
                "value": 0,
                "relatedLot": "1"
            },
            {
                "id": "ocds-kuma6s-127356-bidsstatistic-129818-659",
                "measure": "foreignBidsFromEU",
                "value": 0,
                "relatedLot": "1"
            },
            {
                "id": "ocds-kuma6s-127356-bidsstatistic-129818-660",
                "measure": "foreignBidsFromNonEU",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "ocds-kuma6s-127356-bidsstatistic-129818-661",
                "measure": "electronicBids",
                "value": 1,
                "relatedLot": "1"
            }
        ]
    }
}